The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index; 9 of the 65 sources its claims cite were checked for support.
Suicide risk and mortality among patients with cancer
Abstract
Despite substantial progress in cancer therapy in recent decades, patients with cancer remain at high suicide risk. Data from individual studies have not been comprehensively quantified and specific risk factors are ill-defined. We assessed suicide mortality risk according to cancer prognosis, stage, time since diagnosis, gender, ethnicity, marital status, year of recruitment and geographic region. We searched EMBASE, MEDLINE, PsycINFO, Web of Science, CINAHL and Google Scholar for relevant articles up to February 2021. We used a random effects model, performed meta-regression meta-analysis and assessed heterogeneity and publication bias using I², funnel plots and Egger's and Begg's tests. We performed a systematic review including 62 studies and 46,952,813 patients. To avoid patient sample overlap, the meta-analysis was performed on 28 studies, involving 22,407,690 patients with cancer. Suicide mortality was significantly increased compared with the general population (standardized mortality ratio = 1.85, 95% confidence interval = 1.55-2.20). Risk was strongly related to cancer prognosis, cancer stage, time since diagnosis and geographic region. Patients with cancer, particularly those with specific risk factors, should be closely monitored for suicidality and need specialized care to reduce short- and long-term risks of suicide.
Overview
CoChat Summary
TL;DR
This systematic review and meta-analysis found that patients with cancer had an 85% increased suicide mortality rate compared with the general population (SMR = 1.85, 95% CI = 1.55–2.20). Risk was highest among patients with poor-prognosis cancers, late-stage disease, within the first year after diagnosis, and in the USA.
Key findings
- Overall suicide mortality was significantly increased in patients with cancer versus the general population (SMR = 1.85, 95% CI = 1.55–2.20; I² = 99.37%, P < 0.0001); a sensitivity analysis using all 62 eligible studies yielded SMR = 1.93, 95% CI = 1.71–2.18.
- Suicide mortality differed by cancer prognosis: good prognosis SMR = 1.50 (95% CI = 1.12–2.00), intermediate prognosis SMR = 1.98 (95% CI = 1.56–2.51), and poor prognosis SMR = 3.53 (95% CI = 2.75–4.53; P for difference < 0.001).
- Suicide mortality was higher for late-stage cancer (SMR = 3.12, 95% CI = 2.22–4.38) than early-stage cancer (SMR = 1.50, 95% CI = 1.16–1.94; P < 0.001), and higher within 1 year after diagnosis (SMR = 3.03, 95% CI = 2.09–4.39) than later than 1 year (SMR = 1.39, 95% CI = 1.12–1.72; P < 0.001).
- Geographic region was associated with risk: USA SMR = 2.77 (95% CI = 1.62–4.74), Europe SMR = 1.51 (95% CI = 1.33–1.72), Asia SMR = 1.97 (95% CI = 1.44–2.70), Australia SMR = 1.63 (95% CI = 1.40–1.90; P for difference = 0.01). Gender, ethnicity, year of recruitment, and marital status did not reach statistical significance.
Methods
- Systematic review and random-effects meta-analysis registered in PROSPERO (CRD42021265254); searched EMBASE, MEDLINE, PsycINFO, Web of Science, CINAHL, and Google Scholar up to February 2021, following PRISMA, MOOSE, and PRESS recommendations.
- Included 62 cohort studies comprising 46,952,813 patients with cancer, with 69,398 suicides during at least 107,961,796 person-years; to avoid patient sample overlap, the main meta-analysis used 28 independent studies comprising 22,407,690 patients.
- Analyzed standardized mortality ratios (SMRs) versus the general population; performed subgroup analyses and meta-regression for cancer prognosis, stage, time since diagnosis, gender, ethnicity, marital status, year of recruitment, and geographic region; assessed heterogeneity with I² and publication bias with funnel plots, Egger’s and Begg’s tests.
Limitations
- The paper states it could not address suicidal ideations, suicide attempts, psychiatric comorbidities, depressive symptoms, psychotherapeutic care, or antidepressant therapy, because only one included study focused on suicidal thoughts and attempts and only one considered prediagnosis psychiatric care. It also could not summarize age due to overlapping age categories, could not evaluate physician-assisted death versus suicide, noted that misreporting of suicides cannot be excluded, and stated that adjustment for confounders was not homogeneous across studies.
- The paper states that due to limited data from low-income countries, findings are primarily generalizable to high-income countries.
- Evident from the text: heterogeneity was very high (I² ≈ 99% in main and subgroup analyses), and the authors note that heterogeneity may result from differences in cancer sites, registry documentation, and analytic strategies across primary studies.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
2 Valid · 2 Not valid · 30 Not checked · 106 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Increased suicide rates in patients with cancer compared with the general population have been observed for decades in different populations around the globe 8-23 .”
What the sources say
- Supportedcites [8] Henson, K. E. et al. Risk of suicide after cancer diagnosis in England. JAMA Psychiatry 76, 51–60 (2018). source
The Discussion (Findings in the Context of Other Studies; page unavailable) reports elevated suicide risk in patients with cancer across eight countries. The References list a study covering 1960–1999, while this paper's own Discussion reports increased risk in England, supporting the claim that the observation spans decades. (LLM, conf=0.90)
- Not checked yetcites [9] Allebeck, P., Bolund, C. & Ringback, G. Increased suicide rate in cancer patients. A cohort study based on the Swedish Cancer-Environment Register. J. Clin. Epidemiol. 42, 611–616 (1989). source
- Not checked yetcites [10] Muff Christensen, M. L., Yousaf, U., Engholm, G. & Storm, H. H. Increased suicide risk among Danish women with non-melanoma skin cancer, 1971–1999. Eur. J. Cancer Prev. 15, 266–268 (2006). source
- Supportedcites [11] Crocetti, E., Arniani, S., Acciai, S., Barchielli, A. & Buiatti, E. High suicide mortality soon after diagnosis among cancer patients in central Italy. Br. J. Cancer 77, 1194–1196 (1998). source
The Discussion (pp. 1195–1196) reports increased suicide risk among cancer patients in central Italy and says its findings are consistent with population-based studies in Connecticut, Scandinavia, Switzerland and Japan. It describes studies spanning multiple decades, supporting the broad historical and geographic claim. (LLM, conf=0.91)
- Supportedcites [12] Dormer, N. R., McCaul, K. A. & Kristjanson, L. J. Risk of suicide in cancer patients in Western Australia, 1981–2002. Med. J. Aust. 188, 140–143 (2008). source
The opening section (p. 1) says international population-based studies found increased suicide risk in cancer patients relative to the general population. Its references (p. 4) identify studies from several countries spanning decades, supporting the claim's geographic and historical scope. (LLM, conf=0.92)
- Not checked yetcites [13] Hem, E., Loge, J. H., Haldorsen, T. & Ekeberg, O. Suicide risk in cancer patients from 1960 to 1999. J. Clin. Oncol. 22, 4209–4216 (2004). source
- Not checked yetcites [14] Innos, K., Rahu, K., Rahu, M. & Baburin, A. Suicides among cancer patients in Estonia: a population-based study. Eur. J. Cancer 39, 2223–2228 (2003). source
- Not checked yetcites [15] Levi, F., Bulliard, J. L. & La Vecchia, C. Suicide risk among incident cases of cancer in the Swiss Canton of Vaud. Oncology 48, 44–47 (1991). source
- Not checked yetcites [16] Misono, S., Weiss, N. S., Fann, J. R., Redman, M. & Yueh, B. Incidence of suicide in persons with cancer. J. Clin. Oncol. 26, 4731–4738 (2008). source
- Supportedcites [17] Robinson, D., Renshaw, C., Okello, C., Moller, H. & Davies, E. A. Suicide in cancer patients in South East England from 1996 to 2005: a population-based study. Br. J. Cancer 101, 198–201 (2009). source
The Abstract states that studies from around the world have found increased suicide risk in cancer patients, and describes this study’s comparison with the general population. Another passage in the Abstract lists findings from multiple countries, with cited studies spanning 1979 to 2008, supporting the claim that this has been observed for decades. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
None of the sources cited for this claim have been checked yet.
In the paper
“including only 22 (ref. 25 ), 19 (ref. 24 ), 36 (ref. 26 ), 5 (ref. 27 ), 12 (ref. 28 ) and 5 (ref. 29 ) studies”
What the sources say
- Not checked yetcites [24] Du, L. et al. Incidence of suicide death in patients with cancer: a systematic review and meta-analysis. J. Affect. Disord. 276, 711–719 (2020). source
- Not checked yetcites [25] Harris, E. C. & Barraclough, B. M. Suicide as an outcome for medical disorders. Medicine 73, 281–296 (1994). source
- Not checked yetcites [26] Brunckhorst, O. et al. Depression, anxiety, and suicidality in patients with prostate cancer: a systematic review and meta-analysis of observational studies. Prostate Cancer Prostatic Dis. 24, 281–289 (2021). source
- Not checked yetcites [27] Guo, Z. et al. Incidence and risk factors of suicide among patients diagnosed with bladder cancer: a systematic review and meta-analysis. Urol. Oncol. 39, 171–179 (2020). source
- Could not verifycites [28] Lunny, C., Pieper, D., Thabet, P. & Kanji, S. Managing overlap of primary study results across systematic reviews: practical considerations for authors of overviews of reviews. BMC Med. Res. Method. 21, 140 (2021). sourceExperimental — accuracy not yet measured
Our copy of Lunny et al. (2021) is a methodological paper on managing overlap of primary studies across systematic reviews in overviews; nowhere does it report previous meta-analyses including 22, 19, 36, 5, 12 and 5 studies. Searches for those counts returned only unrelated figures (e.g., Results > Presentation of case studies: '29 (48%) RCTs overlapping across 9 reviews'; 'Twenty-one reviews involving 71 primary studies'; Patnode's '54 included systematic reviews'), plus the Background and Table 1 characteristics of methods studies. The claim's numbers evidently belong to the citing paper's own references 24-29, and our copy neither states nor contradicts them, and does not credit them to any other work. (LLM, conf=0.72)
- Not checked yetcites [29] SEER*Explorer: An interactive website for SEER cancer statistics (National Cancer Institute, 2021). https://seer.cancer.gov/explorer
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Also, the role and efficacy of pharmacological antidepressant treatment among patients with cancer with depressive symptoms have not been well studied, particularly in elderly patients 56,57 .”
What the sources say
- Could not verifycites [56] Boudreaux, E. D. et al. Improving suicide risk screening and detection in the emergency department. Am. J. Prev. Med. 50, 445–453 (2016). sourceExperimental — accuracy not yet measured
The Introduction and Discussion address suicide-risk screening in emergency-department patients, not antidepressant treatment in patients with cancer. Searches for pharmacological antidepressant treatment and for antidepressant efficacy in older cancer patients found no passage addressing whether that treatment has been well studied. (LLM, conf=0.75)
- Could not verifycites [57] Kim, S., Lee, H. K. & Lee, K. Which PHQ-9 items can effectively screen for suicide? Machine learning approaches. Int. J. Environ. Res. Public Health 18, 3339 (2021). sourceExperimental — accuracy not yet measured
The Introduction discusses depression screening and suicide risk, while Materials and Methods describes a PHQ questionnaire dataset; neither addresses antidepressant treatment in patients with cancer. Searches for pharmacological antidepressant treatment and its efficacy in elderly cancer patients found no passage supporting the claim. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Suicide mortality was intermediate (SMR = 1.98, 95% CI = 1.56-2.51) with high heterogeneity between studies”
- Also stated in: § Results · p. 2 · plain
“for cancers known to have a moderate prognosis, including cancers of the breast, female genital system, colon and rectum, urinary system including kidney and bladder, leukemia, non-Hodgkin's lymphoma, Hodgkin's lymphoma and cancers of the connective tissue.”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · p. 2 · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Suicide mortality was high (SMR = 3.12, 95% CI = 2.22-4.38) with high heterogeneity between studies”
- Also stated in: § Results · p. 3 · plain
“for cancers of a late stage, defined as 'distant' , 'advanced' , 'late' or 'M1' .”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · p. 3 · plain
73 more claims
Create a free account to see all 140 claims and to verify the 56 references still open.
- It may state two separate claims as one. 32
- Probably not a substantial claim. 45
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The risk for self-harm and/or suicide has been reported to be 85% higher (standardized mortality ratio, 1.85; 95% CI, 1.55 to 2.20) than for the general population, 39 with the greatest risk during the first 12 months after cancer diagnosis, 40,41 underscoring the importance of screening for the newly diagnosed.42,43”
From Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update (2023) · cites this paper as [39]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“There were 31 studies performed in the USA, 24 in Europe, 1 combined data from both the USA and Europe, 5 were carried out in Asia and 2 were performed in Australia”
Reported 62 · recomputed 63
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Discussion · p. 5
“| Women | Women-specific cancers | Other cancers in women | - |”
§ Discussion · p. 5
“| Women | Other cancers in women | 1.50 | 1.11-2.02 | - | |”
Citations
Cites
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Global Burden of Disease Cancer Collaboration, Fitzmaurice, C., Allen, C., Barber, R. M., Barregard, L., Bhutta, Z. A., Brenner, H., Dicker, D. J., Chimed-Orchir, O., Dandona, R., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5688 · Cited by 6,215
PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement
McGowan, J., Sampson, M., Salzwedel, D. M., Cogo, E., Foerster, V., & Lefebvre, C. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.01.021 · Cited by 5,700
Rethlefsen, M. L., Kirtley, S., Waffenschmidt, S., Ayala, A. P., Moher, D., Page, M. J., Koffel, J. B., PRISMA-S Group, Blunt, H., Brigham, T., et al. (2021) · Systematic Reviews · doi:10.1186/s13643-020-01542-z · Cited by 3,714
Rethlefsen, M. L., Kirtley, S., Waffenschmidt, S., Ayala, A. P., Moher, D., Page, M. J., & Koffel, J. (2019) · doi:10.31219/osf.io/sfc38 · Cited by 3,696
Suicide Prevention Strategies: A Systematic Review
Mann, J. J., Apter, A., Bertolote, J., Beautrais, A., Currier, D., Haas, A., Hegerl, U., Lonnqvist, J., Malone, K., Marusic, A., et al. (2005) · JAMA · doi:10.1001/jama.294.16.2064 · Cited by 2,852
Global Burden of Disease Cancer Collaboration, Fitzmaurice, C., Abate, D., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdel-Rahman, O., Abdelalim, A., Abdoli, A., Abdollahpour, I., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.2996 · Cited by 2,501
Psychological autopsy studies of suicide: a systematic review.
CAVANAGH, J. T. O., CARSON, A. J., SHARPE, M., & LAWRIE, S. M. (2003) · Psychological Medicine · doi:10.1017/s0033291702006943 · Cited by 2,207
Cited by
Lustberg, M. B., Kuderer, N. M., Desai, A., Bergerot, C., & Lyman, G. H. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00776-9 · Cited by 306
Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update
Andersen, B. L., Lacchetti, C., Ashing, K., Berek, J. S., Berman, B. S., Bolte, S., Dizon, D. S., Given, B., Nekhlyudov, L., Pirl, W., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00293 · Cited by 318
“…and/or suicide has been reported to be 85% higher (standardized mortality ratio, 1.85; 95% CI, 1.55 to 2.20) than for the general population, 39 with the greatest risk during the fi rst 12 months after cancer diagnosis, 40,41 underscoring the importance of screening for the newly diagnosed.”
InfluentialIndividual-level risk factors for suicide mortality in the general population: an umbrella review
Favril, L., Yu, R., Geddes, J. R., & Fazel, S. (2023) · The Lancet Public Health · doi:10.1016/s2468-2667(23)00207-4 · Cited by 193
“8,51 Finally, we did not assess the quality of primary studies included in meta-analyses, nor did we re-analyse each meta-analysis with individual study estimates 39 or examine trends over time in terms of risk factor coverage or quality.”
MethodGlobal unmet psychosocial needs in cancer care: health policy
Bergerot, C. D., Jacobsen, P. B., Rosa, W. E., Lam, W., Dunn, J. C., Gonzalez, L. F., Mehnert-Theuerkauf, A., Veeraiah, S., & Li, M. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102942 · Cited by 127
Emerging SERS biosensors for the analysis of cells and extracellular vesicles
Yaraki, M. T., Tukova, A., & Wang, Y. (2022) · Nanoscale · doi:10.1039/d2nr03005e · Cited by 79
Metadata
- Authors
- Heinrich, M., Hofmann, L., Baurecht, H., Kreuzer, P. M., Knüttel, H., Leitzmann, M. F., & Seliger, C.
- Affiliations
- University of Regensburg (DE)
- University Hospital Heidelberg (DE)
- Corresponding author
- Seliger, Corinna
- ORCID
- Venue
- Nature Medicine
- Published
- 2022-03-28
- Volume
- 28
- Issue
- 4
- Pages
- 852-859
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W4220972327
- Cited by
- 136
- References
- 64
- Citations by year
- 2026: 23 · 2025: 37 · 2024: 34 · 2023: 32 · 2022: 10
- FWCI
- 25.78
- Type
- journal article
- Language
- en
- Update notices
- correction (2023-03-20)
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- University of Regensburg Publication Server (University of Regensburg) (acceptedVersion)
- University of Regensburg Publication Server (University of Regensburg) (submittedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- suicide risk, suicide mortality, cancer patients, standardized mortality ratio, cancer prognosis, tumor stage, time since diagnosis, regional variation, psycho-oncology, suicide prevention
- MeSH terms
- Humans, Neoplasms, Risk Factors, Suicide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Suicide risk and mortality among patients with cancer. https://app.cochat.ai/papers/10.1038/s41591-022-01745-y
- The paper
- Heinrich, M., Hofmann, L., Baurecht, H., Kreuzer, P. M., Knüttel, H., Leitzmann, M. F., & Seliger, C. (2022). Suicide risk and mortality among patients with cancer. Nature Medicine. https://doi.org/10.1038/s41591-022-01745-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.